Geller Alan C, Swetter Susan M, Brooks Katie, Demierre Marie-France, Yaroch Amy L
Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
J Am Acad Dermatol. 2007 Oct;57(4):555-72; quiz 573-6. doi: 10.1016/j.jaad.2007.06.032.
In the past 5 years, there have been notable strides toward the earlier recognition and discovery of melanoma, including new technologies to complement and augment the clinical examination and new insights to help clinicians recognize early melanoma. However, incidence and mortality rates throughout most of the developed world have risen over the past 25 years, while education and screening, potentially the best means for reducing the disease, continue to be severely underutilized. Much progress needs to be made to reach middle-aged and older men and persons of lower socioeconomic status who suffer a disproportionate burden of death from melanoma. Worldwide melanoma control must also be a priority, and comprehensive educational and screening programs should be directed to Northern Ireland and a number of Eastern European nations, whose 5-year survival rates range between 53% and 60%, mirroring those of the United States and Australia more than 40 years ago.
After completing this learning activity, participants should be aware of the most recent melanoma epidemiologic data, both in the United States and internationally; worldwide early detection and screening programs; clinical strategies to recognize and improve the detection of early melanoma; the latest technologies for early detection of melanoma; and public and professional education programs designed to enhance early detection.
在过去5年中，在黑色素瘤的早期识别和发现方面取得了显著进展，包括补充和增强临床检查的新技术以及帮助临床医生识别早期黑色素瘤的新见解。然而，在过去25年中，大多数发达国家的发病率和死亡率都有所上升，而教育和筛查作为降低该病的最佳手段，仍未得到充分利用。要接触到黑色素瘤死亡负担过重的中年及老年男性和社会经济地位较低的人群，仍有许多工作要做。全球黑色素瘤控制也必须成为优先事项，全面的教育和筛查计划应针对北爱尔兰和一些东欧国家，这些国家的5年生存率在53%至60%之间，与40多年前的美国和澳大利亚相当。
完成本学习活动后，参与者应了解美国和国际上最新的黑色素瘤流行病学数据；全球早期检测和筛查计划；识别和改进早期黑色素瘤检测的临床策略；早期检测黑色素瘤的最新技术；以及旨在加强早期检测的公共和专业教育计划。
